Table 4 of
Liu, Mol Vis 2016; 22:352-361. Table 4 of
Liu, Mol Vis 2016; 22:352-361.
Table 4. Chemokines in patients with recurrent and treat-naïve wet AMD.
| Chemokines (pg/ml) | recurrent AMD (n=9) | treat-naive AMD (n=7) | p* |
|---|---|---|---|
| IP-10/CXCL10 | 37.19±15.90 | 23.93±7.32 | 0.012 |
| OPN | 35,783±19576.33 | 46,400±28001.29 | 0.408 |
| PARC/CCL18 | 1273.4±932.19 | 1593.5±1309.88 | 0.837 |
| GRO | 110.14±55.02 | 66.56±37.98 | 0.174 |
| HCC-1/CCL14 | 317.84±91.22 | 310.79±55.08 | 0.918 |
| CXCL16 | 1167.8±463.25 | 1076.1±547,57 | 0.837 |
| ENA-78/CXCL5 | 32.49±25.01 | 51.22±11.30 | 0.113 |
| LIGHT/TNFSF14 | 25.05±15.01 | 24.06±12.63 | 1 |
| GCP-2/CXCL6 | 129.24±92.38 | 115.60±70.52 | 0.864 |
| CCL28 | 124.93±45.56 | 132.41±25.68 | 0.918 |
| NAP-2/CXCL7 | 15.92±7.10 | 18.71±6.33 | 0.47 |
| HCC-4/CCL16 | 44.51±24.93 | 33.94±18.67 | 0.351 |
| SDF-1/CXCL12 | 162.31±88.96 | 98.37±25.70 | 0.257 |
| PF4 | 778.14±321.04 | 1020.3±780.25 | 0.95 |
| MDC/CCL22 | 175.39±46.03 | 137.16±37.70 | 0.002 |